Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a novel
biomarker of
LDL clearance and a therapeutic target of
cardiovascular disease. We examined the effects of aerobic exercise training in modulating PCSK9 abundance and hepatic
sterol regulation in high-fat-fed C57BL/6 mice. Mice (n = 8) were assigned to a low-fat (LF), high-fat (HF), or an HF with exercise (HF + EX) group for 8 weeks. The HF + EX group was progressively trained 5 days/week on a motorized treadmill. The HF + EX group was protected against
body weight (BW) gain and diet-induced
dyslipidemia compared with the HF group. The HF + EX group demonstrated an increase in hepatic PCSK9
mRNA (1.9-fold of HF control, P < 0.05) and a reduction in plasma PCSK9 (14%) compared with the HF group. Compared with HF mice, HF + EX mice demonstrated reduced hepatic
cholesterol (14%) and increased (P < 0.05) nuclear
SREBP2 protein (1.8-fold of HF group) and LDLr
mRNA (1.4-fold of HF group). Plasma PCSK9 concentrations correlated positively with plasma non-HDL-C (P = 0.01, r = 0.84). Results suggest that treadmill exercise reduces non-
HDL cholesterol and differentially modulates hepatic and blood PCSK9 abundance in HF-fed C57BL/6 mice.